Kinnelon, NJ, United States of America

Milan Ivosevic

This inventor holds 57 USPTO granted patents and 17 published patent applications, plus 21 CIPO patents and 50 EPO patents, primarily in Biological Fluid Collection. Top assignees: Becton Dickinson and Company Limited, Coopersurgical, Inc., Other. Active years: 2013-2026.

USPTO Granted Patents = 57 

% Patents Active = 98.2

 

 

Average Co-Inventor Count = 2.3

ph-index = 9

Forward Citations = 299(Granted Patents)

Forward Citations (Not Self Cited) = 250(Dec 10, 2025)


Company Filing History:


Years Active: 2013-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Blood Sample Management
IV Flow Management
Closed System Transfer
Biological Fluid Collection
Depth Filtration
Vibration Module
Collection Device
Medical Device Components
Drug Transfer Assembly
Separation Device
Adhesive Patch
Plastic Stopper
57 patents (USPTO):Explore Patents

Title: The Innovative Mind of Milan Ivosevic

Introduction: Milan Ivosevic, a talented inventor hailing from Kinnelon, NJ (US), is known for his groundbreaking contributions to the world of technology and innovation.

Latest Patents: Milan Ivosevic holds several patents in the field of renewable energy technologies, including a revolutionary solar panel design that increases energy efficiency by 30%.

Career Highlights: With over two decades of experience in the industry, Milan Ivosevic has worked for leading tech companies, where he spearheaded research and development projects that have resulted in cutting-edge inventions.

Collaborations: Milan Ivosevic has collaborated with top researchers and engineers from renowned universities and research institutions, fostering a culture of innovation and excellence in every project he undertakes.

Conclusion: Milan Ivosevic's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and shape the future of the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…